Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
Onconova Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
Onconova Therapeutics reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, three executives at Onconova Therapeutics received on average a compensation package of $940K, a 78% increase compared to previous year.
Average pay of disclosed executives at Onconova Therapeutics
Ramesh Kumar, Chief Executive Officer, received $1.2M in total, which increased by 82% compared to 2017. 48% of Kumar's compensation, or $569K, was in salary. Kumar also received $136K in bonus, $442K in option awards, as well as $27K in other compensation.
Steven M. Fruchtman, Chief Medical Officer, received a compensation package of $970K, which increased by 92% compared to previous year. 48% of the compensation package, or $461K, was in salary.
Manoj Maniar, Senior Vice President, Product Development, earned $676K in 2018, a 54% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2019.